Humaira Ilyas, MS-PhD's Avatar

Humaira Ilyas, MS-PhD

@humaira2204

Research Fellow in the Dept. of Biochemistry, Working with Histone Chaperones @einsteinmed. Cancer Biologist, NMR Spectroscopy, Science Communication. Book Lover, & Webseries Buff outside of lab.

42
Followers
69
Following
4
Posts
07.04.2025
Joined
Posts Following

Latest posts by Humaira Ilyas, MS-PhD @humaira2204

4/4 Having moved to #Seattle recently, I’m looking forward to #connect with people here.
Let’s #connect if you are into #protein sciences, #cancer research, #mentoring or just like to #chat about the #craft of doing #science

23.06.2025 21:29 👍 1 🔁 0 💬 0 📌 0

3/4 I’m passionate about #mentoring students, & improving access to #meaningful research #experiences. I’ve #guided high school & #undergraduate students on summer projects. Currently working on #grant writing for early career researchers.

23.06.2025 21:26 👍 1 🔁 0 💬 0 📌 0

2/4 My PhD focussed on #antimicrobial peptides designing, and then as a #postdoc, I studied PTMs in #cancer, especially how protein #glutamylation impacts #leukemia.

23.06.2025 21:22 👍 0 🔁 0 💬 0 📌 0

Hi @bsky.app, I’m Humaira, a molecular biologist and protein scientist passionate about decoding complex biological systems and translating that knowledge into therapeutic insights.

23.06.2025 21:21 👍 2 🔁 0 💬 3 📌 0
Preview
TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia NPM1-mutated acute myeloid leukemia (AML) is defined by aberrant cytoplasmic localization of the mutant NPM1c protein, and therapeutic strategies targeting this specific disease remain limited. Here, ...

We discovered a new AML vulnerability:
TTLL4 glutamylates NPM1c and helps leukemia cells thrive.
Knock it down and cells differentiate and survival improves.
Collab between our lab and @Gritsman_lab—funded by NIH and DoD/CDMRP. Preprint: bit.ly/42oZl09 /1

10.04.2025 14:35 👍 3 🔁 2 💬 1 📌 1

TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia https://www.biorxiv.org/content/10.1101/2025.04.07.647605v1

10.04.2025 02:48 👍 3 🔁 2 💬 0 📌 0

TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia https://www.biorxiv.org/content/10.1101/2025.04.07.647605v1

10.04.2025 02:48 👍 2 🔁 2 💬 0 📌 0